Aktuell weisen die Krankenkassen und der Gesundheitsfonds Überschüsse von über 20 Mrd. Euro auf. Für Daniel Bahr, Bundesminister für Gesundheit, eröffnen diese Überschüsse – neben der Abschaffung der Praxisgebühr – Spielräume für Prämien. Die zentrale Herausforderung an eine...

This article is motivated by the recent health care reform and the general debate on the issues facing the industry, in the wake of the upcoming Supreme Court decision on the matter. It has been argued that the United States spends more on health care as a percentage of its GDP than any other...

This paper focuses on the question: Does public or private control of health care lead to greater healthcare system efficiency? The data analysis demonstrates a curvilinear relationship between government control over health care and health care system inefficiency and that, as a result, a...

The paper provides an analysis of the determinants of health spending differentials among the Italian Regions for the years 1998-2010. An original standardised spending framework is proposed that takes into account the appropriateness of the services provided and price/technical efficiency, as...

Health systems in Western countries are plagued by inefficiency and will likely require a substantial increase in the tax burden as populations age. Patients might also face a gradual decrease in the quality and scope of services. The organisational changes needed to drive costs down and...

Aktuell weisen die Krankenkassen und der Gesundheitsfonds Überschüsse von über 20 Mrd. Euro auf. Für Daniel Bahr, Bundesminister für Gesundheit, eröffnen diese Überschüsse – neben der Abschaffung der Praxisgebühr – Spielräume für Prämien. Die zentrale Herausforderung an eine...

Functions and principles of procurement are made for systemic approach to make right item, at right time, at right place, in right quantity and in reasonable cost. Feasibility and dedication make the system viable. It is a matter of concern that despite of available funds, the materials are not...

Cost-effectiveness analysis is versatile and used widely to assist in health care decision making. This chapter discusses how cost-effectiveness analysis is used at the system or national level, particularly in the domain of coverage and payment policy. We describe its relationship to other...

A decision tree is used to assess the cost effectiveness of adding the type B natriuretic peptid to the revised Lee index of cardiovascular risk. The Lee=3 strategy is cost effective for a WTP lower than Col $11.292.903 at a cost per patient of Col $79.452. Lee strategy with a threshold of 3 has...

There are few studies investigating the consequences of osteoporotic (low bone density) fractures in terms of costs and health outcomes. The purpose of this Swedish pilot study is to assess the costs and quality of life related to fractures of the hip, spine, wrist and shoulder and further to...